Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 3/20 | 0.44 |
| ▸ | GABRB2 | P47870 | 3/20 | 0.44 |
| ▸ | CA2 | P00918 | 6/20 | 0.43 |
| ▸ | CA1 | P00915 | 5/20 | 0.43 |
| ▸ | HPGD | P15428 | 5/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | LMNA | P02545 | 4/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.43 |
| ▸ | EGFR | P00533 | 2/20 | 0.43 |
| ▸ | FYN | P06241 | 2/20 | 0.43 |
| ▸ | MMP9 | P14780 | 2/20 | 0.43 |
| ▸ | RECQL | P46063 | 2/20 | 0.43 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.43 |
| ▸ | MMP2 | P08253 | 1/20 | 0.43 |
| ▸ | MMP8 | P22894 | 1/20 | 0.43 |
| ▸ | CA6 | P23280 | 1/20 | 0.43 |
| ▸ | CDK2 | P24941 | 1/20 | 0.43 |
| ▸ | MMP12 | P39900 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9861539 | 0.85 | GABRA1 (0.48) | GABRA1GABRB2CA2CA1HPGD | |
| SCHEMBL29558466 | 0.85 | TRPA1 (0.50) | GABRA1GABRB2CA2CA1HPGD | |
| SCHEMBL29558146 | 0.84 | TSHR (0.48) | GABRA1GABRB2CA2CA1HPGD | |
| SCHEMBL29559292 | 0.84 | TRPA1 (0.38) | GABRA1GABRB2CA2CA1HPGD | |
| SCHEMBL19971983 | 0.84 | TSHR (0.48) | GABRA1GABRB2CA2CA1HPGD | |
| SCHEMBL17471748 | 0.84 | CES2 (0.42) | GABRA1GABRB2CA2CA1HPGD | |
| SCHEMBL29558423 | 0.84 | CA2 (0.38) | GABRA1GABRB2CA2CA1HPGD | |
| SCHEMBL483998 | 0.82 | KDM4E (0.38) | GABRA1GABRB2HPGDALDH1A1LMNA | |
| SCHEMBL13239923 | 0.80 | TP53 (0.57) | CA2CA1HPGDALDH1A1LMNA | |
| SCHEMBL725385 | 0.80 | GABRA1 (0.52) | GABRA1GABRB2CA2CA1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 471 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4237605-B1 | MELT-SPUN THERMOPLASTIC POLYURETHANE FIBER | LUBRIZOL ADVANCED MAT INC (US) | 2026-04-01 | — | — | EP | claimed |
| US-12515378-B2 | Method of making articles from recyclable fabrics | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2026-01-06 | — | — | US | claimed |
| EP-4648680-A2 | BIOSENSORS WITH HYDROPHILIC POLYURETHANE MEMBRANES | Abbott Diabetes Care Inc. (US) | 2025-11-19 | — | — | EP | claimed |
| US-12391790-B2 | Articles made from hydrophilic thermoplastic polyurethane compositions | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2025-08-19 | — | — | US | claimed |
| WO-2025128433-A1 | MELT-SPUN THERMOPLASTIC POLYURETHANE FIBER AND FABRIC MADE THEREFROM | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2025-06-19 | — | — | WO | claimed |
| EP-4237603-B1 | METHOD OF MAKING ARTICLES FROM RECYCLABLE FABRICS | LUBRIZOL ADVANCED MAT INC (US) | 2025-02-26 | — | — | EP | claimed |
| US-20240328989-A1 | BIOSENSORS WITH HYDROPHILIC POLYURETHANE MEMBRANES | ABBOTT DIABETES CARE INC. (US) | 2024-10-03 | — | — | US | claimed |
| WO-2024151543-A2 | BIOSENSORS WITH HYDROPHILIC POLYURETHANE MEMBRANES | ABBOTT DIABETES CARE INC. (US) | 2024-07-18 | — | — | WO | claimed |
| US-11976159-B2 | Articles made from hydrophilic thermoplastic polyurethane compositions | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2024-05-07 | — | — | US | claimed |
| US-20230382015-A1 | Method of Making Articles from Recyclable Fabrics | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2023-11-30 | — | — | US | claimed |
| US-20130084702-A1 | ACRYLATE POLYURETHANE CHEMICAL MECHANICAL POLISHING LAYER | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2013-04-04 | — | — | US | claimed |
| US-20090074691-A1 | Topical Delivery System for Antiaging and Skin Whitening Agents | BIODERM RESEARCH (US) | 2009-03-19 | — | — | US | claimed |
| CN-100381477-C | Melt spun polyether TPU fibers containing mixed polyols and process | NOVEON IP HOLDINGS CORP (US) | 2008-04-16 | — | — | CN | claimed |
| US-20070149752-A1 | Railway freight car constant contact side bearing | KENNEDY JAMES S | 2007-06-28 | — | — | US | claimed |
| CN-1829754-A | Melt spun polyether TPU fibers containing mixed polyols and process | NOVEON IP HOLDINGS CORP (US) | 2006-09-06 | — | — | CN | claimed |
| CN-1474842-A | Polyester resins with improved properties | �Ĵ����Ǿۺ���ع�����˾ | 2004-02-11 | — | — | CN | claimed |
| US-5558959-A | Polyurethane based electrolytes for electrochemical cells and electrochemical cells using same | MOTOROLA, INC. (US) | 1996-09-24 | — | — | US | claimed |
| US-4762875-A | Water based printing inks for plastic and metal surfaces | GOLD MARVIN H (US) | 1988-08-09 | — | — | US | claimed |
| US-4762865-A | Epoxy coatings for computer hard disks and metal coil decoration and protection | GOLD MARVIN H (US) | 1988-08-09 | — | — | US | claimed |
| US-4652388-A | WATER BASED DISPERSION; ADHESIVE PLASTICIZER AND POLYMER | GOLD MARVIN H (US) | 1987-03-24 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090074691-A1 | Topical Delivery System for Antiaging and Skin Whitening Agents | TYR, MMP17, MMP1 | GABRA1 4083/4885GABRB2 3279/4885CA2 4012/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.